SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-033555
Filing Date
2024-03-19
Accepted
2024-03-19 16:35:40
Documents
78
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tpst-20231231.htm   iXBRL 10-K 2042178
2 EX-4.1 tpst-ex4_1.htm EX-4.1 78190
3 EX-10.26 tpst-ex10_26.htm EX-10.26 80478
4 EX-23.1 tpst-ex23_1.htm EX-23.1 9869
5 EX-31.1 tpst-ex31_1.htm EX-31.1 17537
6 EX-31.2 tpst-ex31_2.htm EX-31.2 17506
7 EX-32.1 tpst-ex32_1.htm EX-32.1 9431
8 EX-97.1 tpst-ex97_1.htm EX-97.1 46071
9 GRAPHIC img41960366_0.jpg GRAPHIC 139551
10 GRAPHIC img41960366_1.jpg GRAPHIC 44015
11 GRAPHIC img41960366_2.jpg GRAPHIC 385105
12 GRAPHIC img41960366_3.jpg GRAPHIC 104315
13 GRAPHIC img41960366_4.jpg GRAPHIC 67150
14 GRAPHIC img41960366_5.jpg GRAPHIC 103490
15 GRAPHIC img41960366_6.jpg GRAPHIC 158457
16 GRAPHIC img41960366_7.jpg GRAPHIC 193689
17 GRAPHIC img41960366_8.jpg GRAPHIC 154000
  Complete submission text file 0000950170-24-033555.txt   10876174

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tpst-20231231.xsd EX-101.SCH 1017926
82 EXTRACTED XBRL INSTANCE DOCUMENT tpst-20231231_htm.xml XML 997769
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35890 | Film No.: 24763981
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)